Position in ABBV
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$1,944,925
+$307,008 QoQ
Shares Held
7,729
+2.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.14%
of 13F equity value
Holder Rank
#1,981
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Nadler Financial Group, Inc. holds $7,548,194 across 7 Drug Manufacturers - General names. ABBV ranks #2 (25.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,767 | $2,119,392 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
7,729 | $1,944,925 | |
| 3 | JNJ |
Johnson & Johnson
|
6,146 | $1,560,899 | |
| 4 | MRK |
Merck & Co., Inc.
|
6,005 | $771,642 | |
| 5 | AMGN |
Amgen Inc
|
1,389 | $502,984 | |
| 6 | PFE |
Pfizer Inc
|
15,802 | $380,512 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,120 | $267,840 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,944,925 | 7,729 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $1,637,917 | 7,531 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $1,925,485 | 8,427 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $2,009,535 | 8,679 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $1,649,048 | 8,884 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $1,984,154 | 9,470 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $1,702,188 | 9,579 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $1,893,635 | 9,589 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $1,649,850 | 9,619 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $1,780,938 | 9,780 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $1,521,185 | 9,816 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $2,075,362 | 13,923 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $1,887,567 | 14,010 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $2,421,308 | 15,193 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $2,454,209 | 15,186 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $2,144,541 | 15,979 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $2,435,703 | 15,903 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $2,569,605 | 15,851 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $2,308,163 | 17,047 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $1,804,449 | 16,728 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $1,789,962 | 15,891 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $1,675,894 | 15,486 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $1,615,071 | 15,073 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $1,490,168 | 17,013 | Shares | Sole | 2020-10-07 | |
| 2020-06-30 | $1,681,332 | 17,125 | Shares | Sole | 2020-07-09 | |
| 2020-03-31 | $1,138,659 | 14,945 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||